Chris Wohn has a robust research background in immunology and psoriasis, holding a PhD from Erasmus MC, where the focus was on mechanisms of psoriatic plaque formation. At CIML, Chris led a collaborative project involving modulating XCR1+ cross-presenting dendritic cells, culminating in a postdoctoral project that investigated the immunobiology of these cells in melanoma. Currently a Senior Scientist at Merus N.V., Chris oversees preclinical bispecific antibody research, manages collaborations, and leads a team in designing and executing complex scientific studies. Prior experience includes a research role at the University of Erlangen-Nuremberg, contributing to a diploma thesis in biological sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices